Aggiornamento Riforma AIFA Condividi:FacebookTwitterLinkedin Post navigation Once‐weekly semaglutide reduces the risk of cardiovascular events in people with type 2 diabetes and polyvascular disease: A post hoc analysisVideo Presidenza AMD 2023-25